CENSOi001-B

FB78R2c2, CENSOi249

General

Cell Line

hPSCreg name CENSOi001-B
Cite as:
CENSOi001-B (RRID:CVCL_LE86)
Alternative name(s)
FB78R2c2, CENSOi249
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CENSOi003-B
(FB79R2c6, CENSOi258)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
CENSOi005-A
(FB76R2c5, CENSOi245)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
CENSOi007-A
(FB75R2c5, CENSOi255)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
CENSOi002-B
(FB74R2c4, CENSOi261)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
MRIi027-A
(DMD 01)
Donor diseases:
Duchenne muscular dystrophy
ICGi002-B
(DMD1_4)
Donor diseases:
Duchenne Muscular Dystrophy
ICGi002-C
(DMD1_11)
Donor diseases:
Duchenne Muscular Dystrophy
RGIe086-A
(SI-180)
Donor diseases:
Duchenne muscular dystrophy
ICGi002-A
(DMD1_1)
Donor diseases:
Duchenne Muscular Dystrophy
ZZUi006-A
(ZZU-iPS-DM1-001)
Donor's gene variants:
DMPK
Donor diseases:
Steinert myotonic dystrophy
CENSOi008-A
(FB77R2c3, CENSOi260)
Donor's gene variants:
DMPK, DMPK
Donor diseases:
myotonic dystrophy type 1
RCi009-A
(Rci201, FB73c6)
Donor's gene variants:
LRIF1, LRIF1
Donor diseases:
Facioscapulohumeral dystrophy
RCi006-A
(FB69c4, RCi169)
Donor's gene variants:
LRIF1, LRIF1
Donor diseases:
Facioscapulohumeral dystrophy
RCi007-A
(FB70c1, RCi170)
Donor's gene variants:
LRIF1, LRIF1
Donor diseases:
Facioscapulohumeral dystrophy
WTSIi658-A
(HPSI0816i-fuuy_3)
Donor diseases:
Spastic paraplegia
WTSIi531-A
(HPSI0616i-kayf_5)
Donor diseases:
Spastic paraplegia
STBCi110-A
(SFC116-03-01)
Donor's gene variants:
CFH
Donor diseases:
type 2 diabetes mellitus
age-related macular degeneration
WTSIi531-B
(HPSI0616i-kayf_6)
Donor diseases:
Spastic paraplegia
WTSIi675-A
(HPSI0616i-iuse_5)
Donor diseases:
Spastic paraplegia
WTSIi675-B
(HPSI0616i-iuse_6)
Donor diseases:
Spastic paraplegia
WTSIi614-B
(HPSI0616i-rily_1)
Donor diseases:
Spastic paraplegia
WTSIi614-A
(HPSI0616i-rily_3)
Donor diseases:
Spastic paraplegia
Last update 14th May 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Censo an Axol Bioscience Company (CENSO)
Distributors

External Databases

BioSamples SAMEA104133950
Cellosaurus CVCL_LE86
EBiSC CENSOi001-B
Wikidata Q54809293

General Information

Publications
Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 5-9

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • DMD
  • Severe dystrophinopathy, Duchenne type
Genetic variants
DMD (target)
Xp21.2-p21.1
A deletion of exons 45 to 50 of the dystrophin gene
Disease associated phenotypes
  • Steroid therapy since age 6 years: Prednisolone 22.5mg (10days on/10days off) until age 9 years then daily treatment; Loss of independent ambulation at 9 years 5 months

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA104133951

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink Dr Joana Domingos
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? Yes
Details on restriction to research project research area restriction to Neuromuscular Research
Does consent permit unforeseen future research, without further consent? Yes
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Does consent permit access to medical records of the donor? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? The London -West London & GTAC Research Ethics Committee
Approval number
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? The London -West London & GTAC Research Ethics Committee
Approval number
Do you have obligations to third parties in regard to the use of the cell line? Yes
Please describe: research area restriction to Neuromuscular Research
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
Age of donor (at collection) 5-9
Collected in 2011
Passage number reprogrammed 5

Reprogramming method

Vector type None

Vector free reprogramming

Type of used vector free reprogramming factor(s)
mRNA
mRNA

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 21 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
TRA 1-60
Yes
POU5F1 (OCT-4)
Yes
SSEA-1
No
SSEA-4
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
GATA6
Yes
CXCR4
Yes
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
VIM
Yes
MIXL1
Yes
NCAM1
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
HES5
Yes
PAX6
Yes
NeuroD1
Yes

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage: 10

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XY
Passage number: 12
Karyotyping method: G-Banding

Other Genotyping (Cell Line)